BeStock  
Markets › Compare › VRDN vs XENE

VRDN vs XENE

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
VRDN · Viridian Therapeutics$29.96 ▼ 4.71%
XENE · Xenon Pharmaceuticals$37.04 ▼ 1.38%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

3470105141176Nov 24, '25May 26, '26Nov 20, '26
  • VRDN -6.5%
  • XENE -11.9%

Head to head

MetricVRDNXENE
Price$29.96$37.04
Change today▼ 4.71%▼ 1.38%
Market cap$3.40B$3.64B
Return, 3 months+24.7%-38.8%
Return, year to date-3.7%-17.4%
Return, 1 year-1.3%-10.0%
P/E (TTM)––
P/B7.03.2
P/E percentile vs own 5y12th97th
Dividend yield––
Revenue growth (YoY, latest qtr)-63.5%–
Net profit growth (YoY)-192.5%-21.5%
Gross margin94.1%–
Operating margin-1,781.4%–
Net margin-1,741.9%–
Return on equity-115.0%-50.3%
Analyst target vs. price+34.9%+98.2%
Analyst buy share100%100%
RSI (14)6441
30-day volatility64.4%39.0%
Max drawdown, 1 year-60.6%-52.8%
Trend readStrong uptrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • XENE is the largest of the group by market value.
  • VRDN has returned the most over the past year.
  • XENE has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top